Health care partner Mark Barnes (Boston) business & securities litigation partner Nicholas Berg, and government enforcement associate Brendan Hanifin (both of Chicago) co-authored an article published by Bloomberg BNA’s Medical Research Law & Policy Report on Jan. 6. The article, titled “Corruption Risks in International Clinical Trials: Navigating Between Anti-Bribery Laws and Local Circumstances,” examines corruption risks in international clinical trials and discusses several proactive steps that clinical trial sponsors and services providers may consider to mitigate the risk.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.